2026 State of Pharmacy Benefits Decisions:
The Churn Trap
7 Data Trends Behind the Most Unsettled Pharmacy Benefits Market in Years
The market is telling us that employers are unhappy, and that they’re acting on it. Three out of four have changed their pharmacy benefits advisor in the past year or plan to in the next. Many are swapping PBMs, too. Built on survey data from 601 employers and 300 advisors, this report shows you where buyers now find value, and what evidence actually earns their confidence.
Inside, you’ll learn how to:
- Understand why advisor influence stays high even as loyalty erodes.
- Position transparency as a baseline, not a selling point.
- Make recommendations that hold up across net cost, service, contract terms, and execution.
- Show clients how active clinical management improves trend in ways a vendor swap can’t.
What advisors need to know in today’s market:
- Buyers want contract comparisons, performance guarantees, and audited savings, not assurances.
- Transparency gets you considered, but it’s results that earn the recommendation.
- Clinical management sits at the center. Employers want a partner who can influence trend, not just report it.
- Employers expect defined GLP-1 strategies, not open-ended coverage.
Don’t let another switch repeat the cycle. Download the report and show your clients why active management, not the next vendor swap, is the way out of the churn trap.
Download the Market Report
Complete the form to access the report.
